Sleep deprivation as a treatment for major depressive episodes: A systematic review and meta-analysis. 2022

Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK; Department of Psychiatry, University of Oxford, Oxford, UK. Electronic address: pamina.mitter@psych.ox.ac.uk.

Sleep deprivation, alone or in combination with pharmacological treatment and as part of a chronotherapy package, is of potential use for people with major depressive episodes, however the evidence base is still conflicting. The aim of this systematic review and meta-analysis is to assess the clinical effects of sleep deprivation in comparison to any other intervention for the acute and long-term treatment of mood disorders. We searched electronic databases and trial registries (last update: 16th October 2021) for published and unpublished randomised controlled trials recruiting participants with a major depressive episode in unipolar or bipolar affective disorder. The clinical outcomes of interest were the reduction in depressive symptoms at different timepoints and the number of participants experiencing at least one side effect. Overall, 29 trials (1246 participants) were included. We did not find any difference in change in symptoms or all-cause discontinuation between interventions including SD compared to a control of the same intervention except without SD. In the included studies there were no available data for adverse events. Using the most methodologically rigorous approach, we did not find evidence that the addition of sleep deprivation to treatment packages leads to enhanced depressive outcomes.

UI MeSH Term Description Entries
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D012892 Sleep Deprivation The state of being deprived of sleep under experimental conditions, due to life events, or from a wide variety of pathophysiologic causes such as medication effect, chronic illness, psychiatric illness, or sleep disorder. Inadequate Sleep,Insufficient Sleep,Insufficient Sleep Syndrome,REM Sleep Deprivation,Sleep Debt,Sleep Fragmentation,Sleep Insufficiency,Deprivation, REM Sleep,Deprivation, Sleep,Fragmentation, Sleep,Insufficiencies, Sleep,Insufficiency, Sleep,Insufficient Sleep Syndromes,Sleep Deprivation, REM,Sleep Insufficiencies,Sleep, Inadequate,Sleep, Insufficient,Syndrome, Insufficient Sleep
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical

Related Publications

Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
January 2021, Acta psychiatrica Scandinavica,
Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
August 2017, Journal of clinical psychopharmacology,
Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
February 2017, JAMA psychiatry,
Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
January 2024, Frontiers in neuroscience,
Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
November 2018, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology,
Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
January 2015, General hospital psychiatry,
Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
January 2023, Pharmacopsychiatry,
Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
April 2024, CNS spectrums,
Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
September 2018, The American journal of psychiatry,
Pamina Mitter, and Franco De Crescenzo, and Kimberley Loo Yong Kee, and Jun Xia, and Samantha Roberts, and Wenjie Chi, and Ayse Kurtulmus, and Simon D Kyle, and John R Geddes, and Andrea Cipriani
January 2023, Frontiers in psychiatry,
Copied contents to your clipboard!